{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:45:06Z","timestamp":1790876706896,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,16]]},"DOI":"10.7759\/cureus.54337","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T06:10:13Z","timestamp":1708150213000},"source":"Crossref","is-referenced-by-count":9,"title":["A Comprehensive Review of the Role of Biomarkers in Early Diagnosis of Parkinson\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Somdutta","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal","family":"Ramteke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-018-1910-4","article-title":"Diagnostic biomarkers for Parkinson's disease at a glance: where are we?","volume":"125","author":"Cova I","year":"2018","unstructured":"Cova I, Priori A. Diagnostic biomarkers for Parkinson's disease at a glance: where are we?. J Neural Transm (Vienna). 2018, 125:1417-32. 10.1007\/s00702-018-1910-4","journal-title":"J Neural Transm (Vienna)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00178","article-title":"Integrated analysis and identification of novel biomarkers in Parkinson\u2019s disease","volume":"10","author":"Chi J","year":"2018","unstructured":"Chi J, Xie Q, Jia J, Liu X, Sun J, Deng Y, Yi L. Integrated analysis and identification of novel biomarkers in Parkinson\u2019s disease. Front Aging Neurosci. 2018, 10:178. 10.3389\/fnagi.2018.00178","journal-title":"Front Aging Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam6003","article-title":"Finding useful biomarkers for Parkinson's disease","volume":"10","author":"Chen-Plotkin AS","year":"2018","unstructured":"Chen-Plotkin AS, Albin R, Alcalay R, et al.. Finding useful biomarkers for Parkinson's disease. Sci Transl Med. 2018, 10:10.1126\/scitranslmed.aam6003","journal-title":"Sci Transl Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical neurology and epidemiology of the major neurodegenerative diseases","volume":"10","author":"Erkkinen MG","year":"2018","unstructured":"Erkkinen MG, Kim MO, Geschwind MD. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2018, 10:a033118. 10.1101\/cshperspect.a033118","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00305","article-title":"Recent advances in biomarkers for Parkinson\u2019s disease","volume":"10","author":"He R","year":"2018","unstructured":"He R, Yan X, Guo J, Xu Q, Tang B, Sun Q. Recent advances in biomarkers for Parkinson\u2019s disease. Front Aging Neurosci. 2018, 10:305. 10.3389\/fnagi.2018.00305","journal-title":"Front Aging Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-017-0183-5","article-title":"Biomarkers for Parkinson's disease: recent advancement","volume":"33","author":"Lotankar S","year":"2017","unstructured":"Lotankar S, Prabhavalkar KS, Bhatt LK. Biomarkers for Parkinson's disease: recent advancement. Neurosci Bull. 2017, 33:585-97. 10.1007\/s12264-017-0183-5","journal-title":"Neurosci Bull"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2014.10.030","article-title":"Biomarkers of Parkinson's disease: present and future","volume":"64","author":"Miller DB","year":"2015","unstructured":"Miller DB, O'Callaghan JP. Biomarkers of Parkinson's disease: present and future. Metabolism. 2015, 64:S40-6. 10.1016\/j.metabol.2014.10.030","journal-title":"Metabolism"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson\u2019s disease","volume":"18","author":"Parnetti L","year":"2019","unstructured":"Parnetti L, Gaetani L, Eusebi P, et al.. CSF and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol. 2019, 18:573-86. 10.1016\/S1474-4422(19)30024-9","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2013.06.005","article-title":"Biomarkers in Parkinson's disease (recent update)","volume":"63","author":"Sharma S","year":"2013","unstructured":"Sharma S, Moon CS, Khogali A, et al.. Biomarkers in Parkinson's disease (recent update). Neurochem Int. 2013, 63:201-29. 10.1016\/j.neuint.2013.06.005","journal-title":"Neurochem Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169299","article-title":"Biomarkers in neurodegenerative diseases: proteomics spotlight on ALS and Parkinson\u2019s disease","volume":"23","author":"Raghunathan R","year":"2022","unstructured":"Raghunathan R, Turajane K, Wong LC. Biomarkers in neurodegenerative diseases: proteomics spotlight on ALS and Parkinson\u2019s disease. Int J Mol Sci. 2022, 23:9299. 10.3390\/ijms23169299","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14809","article-title":"Parkinson's disease biomarkers based on \u03b1-synuclein","volume":"150","author":"Fayyad M","year":"2019","unstructured":"Fayyad M, Salim S, Majbour N, Erskine D, Stoops E, Mollenhauer B, El-Agnaf OM. Parkinson's disease biomarkers based on \u03b1-synuclein. J Neurochem. 2019, 150:626-36. 10.1111\/jnc.14809","journal-title":"J Neurochem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-191844","article-title":"Neurophysiological biomarkers of Parkinson's disease","volume":"10","author":"Waninger S","year":"2020","unstructured":"Waninger S, Berka C, Stevanovic Karic M, et al.. Neurophysiological biomarkers of Parkinson's disease. J Parkinsons Dis. 2020, 10:471-80. 10.3233\/JPD-191844","journal-title":"J Parkinsons Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00612","article-title":"Parkinson\u2019s disease: biomarkers, treatment, and risk factors","volume":"12","author":"Emamzadeh FN","year":"2018","unstructured":"Emamzadeh FN, Surguchov A. Parkinson\u2019s disease: biomarkers, treatment, and risk factors. Front Neurosci. 2018, 12:612. 10.3389\/fnins.2018.00612","journal-title":"Front Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00178-7","article-title":"Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study","volume":"14","author":"Nalls MA","year":"2015","unstructured":"Nalls MA, McLean CY, Rick J, et al.. Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study. Lancet Neurol. 2015, 14:1002-9. 10.1016\/S1474-4422(15)00178-7","journal-title":"Lancet Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/0471142301.ns1001s49","article-title":"Assessment of Parkinson disease manifestations","volume":"10","author":"Perlmutter JS","year":"2009","unstructured":"Perlmutter JS. Assessment of Parkinson disease manifestations. Curr Protoc Neurosci. 2009, 10:Unit10.1. 10.1002\/0471142301.ns1001s49","journal-title":"Curr Protoc Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson's syndrome","volume":"18","author":"Ye H","year":"2023","unstructured":"Ye H, Robak LA, Yu M, Cykowski M, Shulman JM. Genetics and pathogenesis of Parkinson's syndrome. Annu Rev Pathol. 2023, 18:95-121. 10.1146\/annurev-pathmechdis-031521-034145","journal-title":"Annu Rev Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.09.048","article-title":"Biomarkers in Parkinson's disease: advances and strategies","volume":"22","author":"Delenclos M","year":"2016","unstructured":"Delenclos M, Jones DR, McLean PJ, Uitti RJ. Biomarkers in Parkinson's disease: advances and strategies. Parkinsonism Relat Disord. 2016, 22:S106-10. 10.1016\/j.parkreldis.2015.09.048","journal-title":"Parkinsonism Relat Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.200","article-title":"The psychosis spectrum in Parkinson disease","volume":"13","author":"Ffytche DH","year":"2017","unstructured":"Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D. The psychosis spectrum in Parkinson disease. Nat Rev Neurol. 2017, 13:81-95. 10.1038\/nrneurol.2016.200","journal-title":"Nat Rev Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000796","article-title":"Quantitative MRI markers in Parkinson's disease and parkinsonian syndromes","volume":"33","author":"Arribarat G","year":"2020","unstructured":"Arribarat G, P\u00e9ran P. Quantitative MRI markers in Parkinson's disease and parkinsonian syndromes. Curr Opin Neurol. 2020, 33:222-9. 10.1097\/WCO.0000000000000796","journal-title":"Curr Opin Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-017-0174-6","article-title":"Can biomarkers help the early diagnosis of Parkinson\u2019s disease?","volume":"33","author":"Le W","year":"2017","unstructured":"Le W, Dong J, Li S, Korczyn AD. Can biomarkers help the early diagnosis of Parkinson\u2019s disease?. Neurosci Bull. 2017, 33:535-42. 10.1007\/s12264-017-0174-6","journal-title":"Neurosci Bull"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.10.002","article-title":"MRI biomarkers of motor and non-motor symptoms in Parkinson's disease","volume":"73","author":"Ryman SG","year":"2020","unstructured":"Ryman SG, Poston KL. MRI biomarkers of motor and non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord. 2020, 73:85-93. 10.1016\/j.parkreldis.2019.10.002","journal-title":"Parkinsonism Relat Disord"},{"key":"ref22","article-title":"Cerebrospinal fluid biomarkers for the early diagnosis of Parkinson\u2019s disease","volume":"24","author":"da Costa AG","year":"2011","unstructured":"da Costa AG, Gago MF, Garrett C. Cerebrospinal fluid biomarkers for the early diagnosis of Parkinson\u2019s disease. Acta Med Port. 2011, 24:761-8.","journal-title":"Acta Med Port"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001098","article-title":"CSF biomarkers and clinical progression of Parkinson disease","volume":"84","author":"Hall S","year":"2015","unstructured":"Hall S, Surova Y, \u00d6hrfelt A, Zetterberg H, Lindqvist D, Hansson O. CSF biomarkers and clinical progression of Parkinson disease. Neurology. 2015, 84:57-63. 10.1212\/WNL.0000000000001098","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-021-00327-x","article-title":"Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease","volume":"27","author":"Meles SK","year":"2021","unstructured":"Meles SK, Oertel WH, Leenders KL. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease. Mol Med. 2021, 27:111. 10.1186\/s10020-021-00327-x","journal-title":"Mol Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.1312","article-title":"Emerging neuroimaging biomarkers across disease stage in Parkinson disease: a review","volume":"78","author":"Mitchell T","year":"2021","unstructured":"Mitchell T, Leh\u00e9ricy S, Chiu SY, Strafella AP, Stoessl AJ, Vaillancourt DE. Emerging neuroimaging biomarkers across disease stage in Parkinson disease: a review. JAMA Neurol. 2021, 78:1262-72. 10.1001\/jamaneurol.2021.1312","journal-title":"JAMA Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-017-0076-6","article-title":"Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts","volume":"6","author":"Saeed U","year":"2017","unstructured":"Saeed U, Compagnone J, Aviv RI, Strafella AP, Black SE, Lang AE, Masellis M. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener. 2017, 6:8. 10.1186\/s40035-017-0076-6","journal-title":"Transl Neurodegener"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.660379","article-title":"MicroRNA dysregulation in Parkinson\u2019s disease: a narrative review","volume":"15","author":"Nies YH","year":"2021","unstructured":"Nies YH, Mohamad Najib NH, Lim WL, Kamaruzzaman MA, Yahaya MF, Teoh SL. MicroRNA dysregulation in Parkinson\u2019s disease: a narrative review. Front Neurosci. 2021, 15:660379. 10.3389\/fnins.2021.660379","journal-title":"Front Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060912","article-title":"The future of targeted gene-based treatment strategies and biomarkers in Parkinson\u2019s disease","volume":"10","author":"Polissidis A","year":"2020","unstructured":"Polissidis A, Petropoulou-Vathi L, Nakos-Bimpos M, Rideout HJ. The future of targeted gene-based treatment strategies and biomarkers in Parkinson\u2019s disease. Biomolecules. 2020, 10:912. 10.3390\/biom10060912","journal-title":"Biomolecules"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and inflammation\u2014an interesting interplay in Parkinson\u2019s disease","volume":"21","author":"Marogianni C","year":"2020","unstructured":"Marogianni C, Sokratous M, Dardiotis E, Hadjigeorgiou GM, Bogdanos D, Xiromerisiou G. Neurodegeneration and inflammation\u2014an interesting interplay in Parkinson\u2019s disease. Int J Mol Sci. 2020, 21:8421. 10.3390\/ijms21228421","journal-title":"Int J Mol Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010712","article-title":"Role and dysregulation of miRNA in patients with Parkinson\u2019s disease","volume":"24","author":"Salemi M","year":"2022","unstructured":"Salemi M, Marchese G, Lanza G, et al.. Role and dysregulation of miRNA in patients with Parkinson\u2019s disease. Int J Mol Sci. 2022, 24:712. 10.3390\/ijms24010712","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719807","article-title":"Targeting microglial \u03b1-synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s disease","volume":"12","author":"Li Y","year":"2021","unstructured":"Li Y, Xia Y, Yin S, et al.. Targeting microglial \u03b1-synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s disease. Front Immunol. 2021, 12:719807. 10.3389\/fimmu.2021.719807","journal-title":"Front Immunol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2174\/1573406411666151030112140","article-title":"miRNAs as circulating biomarkers for Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"12","author":"Mushtaq G","year":"2016","unstructured":"Mushtaq G, Greig NH, Anwar F, et al.. miRNAs as circulating biomarkers for Alzheimer\u2019s disease and Parkinson\u2019s disease. Med Chem. 2016, 12:217-25. 10.2174\/1573406411666151030112140","journal-title":"Med Chem"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2019.03.002","article-title":"The neuropsychiatry of Parkinson disease: a perfect storm","volume":"27","author":"Weintraub D","year":"2019","unstructured":"Weintraub D, Mamikonyan E. The neuropsychiatry of Parkinson disease: a perfect storm. Am J Geriatr Psychiatry. 2019, 27:998-1018. 10.1016\/j.jagp.2019.03.002","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29171","article-title":"Serum microRNAs predict isolated rapid eye movement sleep behavior disorder and Lewy body diseases","volume":"37","author":"Soto M","year":"2022","unstructured":"Soto M, Iranzo A, Lahoz S, et al.. Serum microRNAs predict isolated rapid eye movement sleep behavior disorder and Lewy body diseases. Mov Disord. 2022, 37:2086-98. 10.1002\/mds.29171","journal-title":"Mov Disord"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.744942","article-title":"MicroRNAs play a role in Parkinson\u2019s disease by regulating microglia function: from pathogenetic involvement to therapeutic potential","volume":"14","author":"Li S","year":"2021","unstructured":"Li S, Bi G, Han S, Huang R. MicroRNAs play a role in Parkinson\u2019s disease by regulating microglia function: from pathogenetic involvement to therapeutic potential. Front Mol Neurosci. 2021, 14:744942. 10.3389\/fnmol.2021.744942","journal-title":"Front Mol Neurosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/184799-a-comprehensive-review-of-the-role-of-biomarkers-in-early-diagnosis-of-parkinsons-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T06:10:17Z","timestamp":1708150217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/184799-a-comprehensive-review-of-the-role-of-biomarkers-in-early-diagnosis-of-parkinsons-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.54337","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,16]]}}}